BETA

Activities of Paul RÜBIG related to 2012/2219(DEC)

Shadow reports (1)

REPORT on discharge in respect of the implementation of the budget of the Innovative Medicines Initiative Joint Undertaking for the financial year 2011 PDF (167 KB) DOC (85 KB)
2016/11/22
Committee: CONT
Dossiers: 2012/2219(DEC)
Documents: PDF(167 KB) DOC(85 KB)

Amendments (4)

Amendment 2 #
Proposal for a decision 1
Paragraph 1
1. ...Postpones the decision to grant the Executive Director of the Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines discharge in respect of the implementation of the Joint Undertaking's budget for the financial year 2011;
2013/02/27
Committee: CONT
Amendment 5 #
Proposal for a decision 1
Paragraph 1
1. ...Grants the Executive Director of the Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines discharge in respect of the implementation of the Joint Undertaking's budget for the financial year 2011;
2013/02/27
Committee: CONT
Amendment 9 #
Motion for a resolution
Paragraph 2
2. Is concerned that the implementation rate for the 159 million euro commitment appropriations available for research activities was 66 % and it was implemented through a global commitment covering the fourth call for proposals; reiterates its concerned about the low implementation rate of the budget and, moreover, about the underlying activities of the Joint Undertaking,; takes duly note that the high level of unused appropriations of the administrative budget (44 %) indicates that it was not based on realistic estimates; calls for a detailed progress report on these shortcomings which makes specific proposals for a gradual improvement in the implementation rate and for a more realistic estimate of the financial resources needed;
2013/02/27
Committee: CONT
Amendment 11 #
Motion for a resolution
Paragraph 4 a (new)
4a. Calls therefore for a detailed progress report which makes specific proposals for a gradual reduction in the error rate;
2013/02/27
Committee: CONT